Sun Pharma Advanced Research Company Ltd Q1 FY2024-2025 Results: Summary

Revenue
₹18.37Cr
Net Profits
₹-95.90Cr
Net Profit Margins
-522.05%

Highlights

Revenue:

Sun Pharma Advanced Research Company Ltd’s revenue fell -46.19% since last year same period to ₹18.37Cr in the Q1 2024-2025. On a quarterly growth basis, Sun Pharma Advanced Research Company Ltd has generated -12.36% fall in its revenue since last 3-months.

Net Profits:

Sun Pharma Advanced Research Company Ltd’s net profit fell -0.58% since last year same period to ₹-95.90Cr in the Q1 2024-2025. On a quarterly growth basis, Sun Pharma Advanced Research Company Ltd has generated 9.35% jump in its net profits since last 3-months.

Net Profit Margins:

Sun Pharma Advanced Research Company Ltd’s net profit margin fell -86.92% since last year same period to -522.05% in the Q1 2024-2025. On a quarterly growth basis, Sun Pharma Advanced Research Company Ltd has generated -3.43% fall in its net profit margins since last 3-months.

FAQs

The revenue for Sun Pharma Advanced Research Company Ltd in the Q1 results 2024 was ₹18.37Cr.

The net profit for Sun Pharma Advanced Research Company Ltd in the Q1 results 2024 was ₹-95.90Cr.

The net profit margin for Sun Pharma Advanced Research Company Ltd in the Q1 results 2024 was -522.05%.

The revenue for Sun Pharma Advanced Research Company Ltd in the Q1 results 2023 was ₹34.14Cr.

The net profit for Sun Pharma Advanced Research Company Ltd in the Q1 results 2023 was ₹-95.35Cr.

The net profit margin for Sun Pharma Advanced Research Company Ltd in the Q1 results 2023 was -279.29%.